Zhang M

An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression.

Shrestha R, Chesner LN, Zhang M, ..., Quigley DA, Feng FY

Cancer Res. 84 (18) 3086-3100 [2024-09-16; online 2024-07-11]

Arian Lundberg DDLS Fellow

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer.

Zhao SG, Bootsma M, Zhou S, ..., Lupien M, Feng FY

Nat. Genet. 56 (8) 1689-1700 [2024-08-00; online 2024-07-17]

Arian Lundberg DDLS Fellow

Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression.

Zhang M, Sjöström M, Cui X, ..., Feng FY, Quigley DA

Nat. Cell Biol. 26 (7) 1176-1186 [2024-07-00; online 2024-06-13]

Arian Lundberg DDLS Fellow

The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.

Lundberg A, Zhang M, Aggarwal R, ..., Small EJ, Quigley DA

Cancer Res. 83 (16) 2763-2774 [2023-08-15; online 2023-06-08]

Arian Lundberg DDLS Fellow

Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer.

Feng E, Rydzewski NR, Zhang M, ..., Sjöström M, Zhao SG

Clin. Cancer Res. 28 (24) 5396-5404 [2022-12-15; online 2022-10-20]

Arian Lundberg DDLS Fellow

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.

Sjöström M, Zhao SG, Levy S, ..., Quigley DA, Feng FY

Cancer Res. 82 (21) 3888-3902 [2022-11-02; online 2022-10-18]

Arian Lundberg DDLS Fellow